Immunic (IMUX) Total Liabilities (2013 - 2026)
Immunic (IMUX) posted Total Liabilities of $38.5 million for Q1 2026, up 25.33% sequentially from $30.7 million in Q4 2025, and up 49.25% YoY from $25.8 million in Q1 2025.
Immunic (IMUX) Total Liabilities (2013 - 2026) Analysis & Trends
Immunic has reported Total Liabilities for 14 years, with the latest figure at $38.5 million in Q1 2026.
- Quarterly Total Liabilities rose 49.25% year-over-year to $38.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.5 million (up 49.25% YoY) and the FY2025 annual result came in at $30.7 million, up 36.93% from the prior year.
- Total Liabilities climbed to $38.5 million in Q1 2026 per IMUX's latest filing, from $30.7 million in the prior quarter.
- Over five years, Total Liabilities peaked at $38.5 million in Q1 2026 and troughed at $10.8 million in Q2 2022.
- A 5-year average of $21.9 million and a median of $22.4 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities plunged 30.78% in 2022, then surged 80.31% in 2023.
- Over 5 years, Total Liabilities stood at $14.1 million in 2022, then soared by 80.31% to $25.4 million in 2023, then fell by 11.55% to $22.4 million in 2024, then jumped by 36.93% to $30.7 million in 2025, then increased by 25.33% to $38.5 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $38.5 million, $30.7 million, and $30.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 31.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.59 Mn |
| Mar 31, 2026 | 38.51 Mn |
| Dec 31, 2025 | 30.73 Mn |
| Sep 30, 2025 | 30.21 Mn |
| Jun 30, 2025 | 27.52 Mn |
| Mar 31, 2025 | 25.80 Mn |
| Dec 31, 2024 | 22.44 Mn |
| Sep 30, 2024 | 23.54 Mn |
| Jun 30, 2024 | 22.92 Mn |
| Mar 31, 2024 | 20.58 Mn |
| Dec 31, 2023 | 25.37 Mn |
| Sep 30, 2023 | 18.57 Mn |
| Jun 30, 2023 | 19.46 Mn |
| Mar 31, 2023 | 17.65 Mn |
| Dec 31, 2022 | 14.07 Mn |
| Sep 30, 2022 | 12.27 Mn |
| Jun 30, 2022 | 10.81 Mn |
| Mar 31, 2022 | 11.96 Mn |
| Dec 31, 2021 | 11.99 Mn |
| Sep 30, 2021 | 11.29 Mn |